|| Home || SEARCH|| Contact || Free Research Publications  ||  Eshop || Privacy Statement ||
RIRDC Completed Projects in 2005-2006 & Research in Progress as at June 2006

BACK TO INDEX

To Horses Completed Projects
 
 
2.4 HORSES - RESEARCH IN PROGRESS
PROJECT No PROJECT TITLE RESEARCHER PHONE ORGANISATION
To improve the management of growing and developing horses
UM-70A The role of macrophages in recovery from exercise induced pulmonary haemorrhage (EIPH) Dr Peter Finnin (03) 9731 2270 The University of Melbourne
UMU-33A Risk factor for gastric ulceration in thoroughbred racehorses A/Prof Guy Lester (08) 9360 7676 Murdoch University
To improve the overall health and welfare of the horse
RAS-1A An investigation into the detection of three common veterinary pharmaceuticals Dr John Vine (03) 9376 6760 Racing Analytical Services Ltd
UQ-121A DNA typing of urine samples to confirm the donor identity Dr Ann Trezise (07) 3365 3647 The University of Queensland
To keep Australia free from major exotic equine disease out-breaks and limit the impact of endemic diseases
UCS-35A Investigating the role of impaired glucose uptake in laminitis Dr Martin Sillence (02) 6933 2205 Charles Sturt University
UM-71A Integrated pest management for the horse farm Prof Ary Hoffmann (03) 9479 2769 La Trobe University
EQS-1A Placentitis: A major cause of late term foetal loss in thoroughbred mares Dr Joan Carrick (07) 4691 0164 Equine Specialist Consulting
To encourage informed use of modern genetic technology and techniques
UMO-36A The development of horse embryonic stem cells (eESCs) Prof Alan Trounson (03) 9905 0771 Monash University
Respiratory Diseases-Improving the Respiratory Health of Horses
US-118A Development of improved treatment and prevention strategies for inflammatory airway disease of horses Dr Jennifer Hodgson (02) 4655 0760 University of Melbourne
Nutrition Research-Development Better Ways to Feed Horses
UNE-87A Understanding and managing variable starch digestion in the horse Dr Geoff Hinch (02) 6773 2202 University of New England
Lameness and Limb Injury-Developing More Effective Methods for Prevention, Diagnosis and Treatment
UQ-118A Laminitis preventive and therapeutic strategies Dr. Christopher Pollitt (07) 3365 2063 The University of Queensland
Other
UQ-111A Epaxial musculature and its relationship with back pain in the horse Dr Catherine McGowan (07) 5460 1521 University of Queensland
UQ-115A Role of bacteria and lactic acid in the pathogenesis of gastric ulceration Dr Rafat Al Jassim (07) 5460 1521 University of Queensland

 
 
 

Research in Progress – To improve the management of growing and developing horses
 
Project Title The role of macrophages in recovery from exercise induced pulmonary haemorrhage (EIPH)
RIRDC Project No.: UM-70A
Start Date: 01-Aug-2004
Finish Date: 31-Aug-2007
Researcher:  Dr Peter Finnin
Organisation: The University of Melbourne
Phone: (03) 9731 2270
Fax: (03) 9731 2366
Email: pfinnin@unimelb.edu.au
Objectives ·1 Identify the major mechanisms of chronic lung lesions induced by EIPH.

·2 Develop methods for reducing chronic ling damage by modulating macrophage-related events after episodes of EIPH.

·3 Use a range of diagnostic imaging modalities to document changes to lungs following EIPH, in order to improve in vivo diagnosis of EIPH.

Current Progress Macrophages play a key role in the control of inflammatory responses. Previous work has demonstrated that the presence of blood within the lung provokes a macrophage dominated inflammatory response, and that this is associated with the development of pulmonary fibrosis.

Current work has involved isolation of alveolar macrophages and examination of the changes in gene expression that occur when alveolar macrophages are exposed to glutaraldehyde-fixed red blood cells (RBC).

Gene expression has been monitored using an immune gene targeted microarray composed of probes for 30 equine and 105 porcine genes known to be involved in immune responses. 

RNA was isolated from control macrophages or macrophages that had been exposed to RBC. The RNA was converted to cDNA, labelled with a fluorescent dye and hybridised to microarray slides. Slides were scanned to determine the fluorescence intensity of each spot on the array that represented a gene of interest. The fluorescence intensity of the spots depends on the abundance of the gene transcripts in the original RNA. By comparing fluorescence intensity of gene spots from control microarray slides to gene spots from microarray slides hybridised with cDNA derived from macrophages exposed to RBC, it was possible to identify genes that are differentially regulated.

We have identified several cytokines, cytokines receptors and transcription factor regulators as being differentially regulated in macrophages phagocytosing RBC. These may have potential as therapeutic agents for aiding recovery from EIPH in affected horses. 

After validation of the differential expression of these candidate genes by real-time PCR, in vitro manipulation of macrophage functions using the candidate agents will be attempted, before moving to in vivo experiments with the most promising candidate agent(s).

Research in Progress – To improve the management of growing and developing horses
 
Project Title Risk factor for gastric ulceration in thoroughbred racehorses
RIRDC Project No.: UMU-33A
Start Date: 01-Jul-2005
Finish Date: 30-Jun-2006
Researcher:  A/Prof Guy Lester
Organisation: Murdoch University
Phone: (08) 9360 7676
Fax: (08) 9360 2603
Email: G.Lester@murdoch.edu.au
Objectives ·1 The specific aim of the proposed research is to examine the relationship between management practices and the point prevalence of gastric squamous mucosal ulceration in Thoroughbred racehorses

·2 To investigate the relationship between ulcer prevalence and defined horse factors including, but not limited to, age, gender, weeks in work, numbers of races this campaign, number of campaigns, and concurrent medication

·3 To investigate the relationship between ulcer prevalence and training stable. 

Current Progress To date we have performed gastroscopy on more than 300 
Thoroughbred racehorses from 23 different training establishments. These represent rural, semi-rural and urban stable environments. We have confirmed a wide variation in point prevalence and ulcer severity between stables. We have collected a large amount of data on each horse and on each training operation and remain hopeful of identifying key risk factors for the development and maintenance of ulcers. We plan to perform the procedure on at least 200 more horses before completing the final statistical analysis.

 

Research in Progress – To improve the overall health and welfare of the horse
 
Project Title An investigation into the detection of three common veterinary pharmaceuticals
RIRDC Project No.: RAS-1A
Start Date: 31-Jul-2005
Finish Date: 30-Jun-2006
Researcher:  Dr John Vine
Organisation: Racing Analytical Services Ltd
Phone: (03) 9376 6760
Fax: (03) 9376 6875
Email: jvine@rasl.com.au
Objectives ·4 The purpose of this research is to study the absorption, distribution, metabolism and excretion of 3 therapeutic substances, frusemide, betamethasone and triamcinolone acetonide, commonly used by veterinarians during the preparation of horses for competition in the thoroughbred and standardbred industries as will as in high level equestrian events.

·5 Frusemide is a high ceiling diuretic commonly used in the management of exercise induced pulmonary haemorrhage in racehorses. Batemethasone and trimcinolone acetetonide are corticosteroid drugs used for intra-articular treatment and/or management of horses with degenerative joint disease.

·6 Several of the analytical procedures used to detect these drugs in urine samples from competing horses are abut to change. These changes may alter the detection periods of these commonly-used drugs. The proposed project will provide reliable and up-to-date drug excretion data for frusemide practising veterinarians in a meaningful number of horses. Pilot studies involving the corticosteroid drugs are aimed at providing preliminary data on likely detection periods. This will be a first step in providing information on responsible use of intra-articular corticosteroids which is consistent with animal welfare and the racing industry's rules on the use of medications in racehorses

Current Progress Administrations of the drugs, frusemide and betamethasone have been successfully completed and all required specimens have been collected. Administrations of triamcinolone acetonide have been completed in approximately half of the horses in the study group.

Sampling of synovial fluid was well-tolerated by the horses in the betamethasone study with no signs of significant discomfort observed. Reasonable quantities of synovial fluid for experimental purposes were obtained.

Analytical methods consistent with the criteria specified by the European Horseracing Scientific Liaison Committee have been developed and validated. This will ensure the data generated in these studies will be compatible with data from related studies currently being carried out in Europe.

Preliminary analytical work has shown that the specimens collected are suitable for the purposes of these studies and that there do not appear to be any anomalous findings which might indicate problems in drug administration, sampling, collection or storage.

Detailed analytical work is now in progress to accurately measure the absorption, distribution, metabolism and excretion of the 3 drugs. In addition, other parameters such as urine specific gravity, urinary creatinine and blood and urinary hydrocortisone concentrations will also be measured as part of an assessment of each drug’s effects.


 

Research in Progress – To improve the overall health and welfare of the horse
 
Project Title DNA typing of urine samples to confirm the donor identity
RIRDC Project No.: UQ-121A
Start Date: 01-Jul-2005
Finish Date: 30-May-2007
Researcher:  Dr Ann Trezise
Organisation: The University of Queensland
Phone: (07) 3365 3647
Fax: (07) 3365 4899
Email: ann.trezise@uq.edu.au
Objectives ·1 Test various methods for DNA typing of horse urine samples.

·2 Establish and optimise a method that is reliable for drug-test positive samples.

·3 Validate and refine the procedure for routine operation.

·4 Implement as a standard operating procedure in the industry.

Current Progress ·5 We have developed a method that successfully and consistently isolates high quality DNA from horse urine samples.

·6 This is an important milestone in this project as it is well known that urine is not a particularly good source of genomic DNA and it is often difficult to obtain high quality DNA consistently.

·7 We have trailed various methods of storage of urine samples prior to DNA extraction and found that refrigeration is the best method of storage. DNA extracted from urine stored at 4°C showed the lowest levels of degradation and produced the highest yield of genomic DNA. Urine that was stored frozen at -20°C provided much lower yields of genomic DNA and overall this DNA showed evidence of more extensive degradation.

·8 This important progress will be reported at the Equine Science Symposium June 13th & 14th at the Gold Coast.

·9 We have begun optimising the generation of DNA profiles from the DNA extracted from urine and are currently determining the optimal DNA concentration to add to the DNA amplification reagents.

·10 The next immediate priority is to obtain both drug-test positive and drug-test negative horse urine that has been collected using the standard collection procedures used by the drug testing authorities to determine whether these procedures introduce any contaminants that impact on the generation of DNA profiles from these samples.


 

Research in Progress – To keep Australia free from major exotic equine disease outbreaks and limit the impact of endemic diseases
 
Project Title Investigating the role of impaired glucose uptake in laminitis
RIRDC Project No.: UCS-35A
Start Date: 01-Aug-04
Finish Date: 30-May-07
Researcher:  Prof Martin Sillence
Organisation: Charles Sturt University
Phone: (02) 6933 2205
Fax: (02) 6933 2812
Email: msillence@csu.edu.au
Objectives ·11 Our aim is to understand the mechanisms that control glucose uptake in the hoof, then identify the factors associated with endocrine and metabolic abnormalities that lead to impaired glucose uptake, tissue starvation and laminitis.
Current Progress The mechanism of laminitis is not known, but the condition can be triggered by several causes that are associated with a change in hormone levels, particularly those hormones that regulate glucose metabolism, such as adrenaline, insulin and cortisol. 

Initially, we believed that laminitis was caused by glucose starvation in the hoof, as the lamellae and hoof wall separate easily when hoof explants are incubated without glucose. Furthermore, our experiments have shown that a synthetic version of adrenaline can decrease glucose uptake by the hoof, consistent with a link between stress, adrenaline, glucose and laminitis. However, we have also found a large degree of individual variation in the sensitivity and responsiveness of horses to adrenaline, and a similar amount of variation in the number of adrenaline receptors in the hoof. This may explain why some horses are more susceptible to laminitis than others. 

Studies elsewhere have confirmed that insulin plays a central role in laminitis, but we have shown that in this case, the mechanism is unlikely to be impaired glucose uptake. We are currently investigating alternative mechanisms, with a view to finding new therapies for this crippling disease.


 

Research in Progress – To keep Australia free from major exotic equine disease outbreaks and limit the impact of endemic diseases
 
Project Title Integrated pest management for the horse farm
RIRDC Project No.: UM-71A
Start Date: 01-Sep-2004
Finish Date: 30-Nov-2006
Researcher:  Prof Ary Hoffmann
Organisation: La Trobe University
Phone: (03) 9479 2769
Fax: (03) 9479 2361
Email: a.hoffman@latrobe.edu.au
Objectives ·12 To complete a research and development project on an alternative to current equine parasite management. To develop a biological control program that retains and environmentally sustainable horse farm, by identifying native ground dwelling predators that break the lifecycle of horse parasites. The lifecycle of horse parasites has a ground dwelling stage that is vulnerable to native and exotic predators. The predator's lifestyle will be studied in relation to the effects of various horse wormers. Exotic dung beetles will be established on horse farms that help to aerate and fertilise the pasture, increasing water absorbency and reducing faecal run-off into farm and community water supply.
Current Progress The ground dwelling invertebrates monitored in pitfall traps on horse farms have been identified and quantified over the past 2 years. Predators retrieved from these traps that may attack horse parasite eggs and larvae are staphylinids, carabid larvae, predatory mites, ants, spiders, ladybird larvae and lacewing larvae. The dung has been monitored for invertebrates and many have been found such as dung beetles, staphylinids, predatory mites, beetles, ants, collembolla, millipedes, spiders, flies and earwigs. These invertebrates may not all predate on parasites but the breaking up of the dung by these animals facilitates decomposition. Continual use of some antihelminths is detrimental to these composting insects. Although some antihelminths do not cause mortality of adult dung beetles, newly emerged beetles are susceptible, and there is other evidence that the larvae feeding on contaminated dung are developmentally impaired (Wardaugh). Monitoring has indicated that pests such as redheaded cockchafers, blackheaded cockchafers and conical snails are a significant pest on the horse farm as they can greatly reduce pasture quality and quantity.

We have found some literature on the effect of dung beetle activity in cattle dung on the parasites of cattle but little work has been done with conclusive results on horse dung. We have included experiments in the project to provide significant information needed to develop a sustainable management program to lessen the use of chemicals for control of horse parasites.

Fecal egg counts on horses at the trial sites are being reported monthly to relevant horse owners. Through this information we have found resistance in worms to the current antihelminths. We have also found that rotation of brand name antihelminths is being confused with rotation of the active chemical. The frequent use of antihelminths and no rotation of active chemical have serious consequences for the horse industry. Information gained from this project is currently being delivered to the equestrian industry through talks and media articles. 

Research in Progress – To keep Australia free from major exotic equine disease outbreaks and limit the impact of endemic diseases
 
Project Title Placentitis: A major cause of late term foetal loss in thoroughbred mares
RIRDC Project No.: EQS-1A
Start Date: 01-Jan-05
Finish Date: 01-Jan-07
Researcher:  Dr Joan Carrick
Organisation: Equine Specialist Consulting
Phone: (02) 6545 1333
Email: joan.carrick@sconevet.com.au
Objectives · The primary objective of this study is to document the development and consequences of placental abnormalities occurring during the second half of gestation in thoroughbred broodmares.

· To correlate placental changes detected in mares by ultrasound, with gross and histopathological evidence of placentitis.

· To determine the incidence of placentitis in normal thoroughbred mares and in 'high risk' mares, ie mares with histories of late term abortion, premature delivery or delivery of a foal with intrauterine growth retardation.

· To monitor the development and progression of placental abnormalities detected by ultrasound in normal and high risk thoroughbred mares.

· To determine whether equine foetal and neonatal weight and health are correlated with placental abnormalities detected by ultrasound.

Current Progress During the 2005 breeding season 30 mares were enrolled in the study, 16 normal mares and 14 "high risk" mares. Two of the high risk mares were not pregnant at the start of the project. Over 200 ultrasound images of the mare’s placentas were collected. The width and characteristics of the placenta and the size and activity of each foetus was recorded every 4 weeks until each mare was 320 days of gestation. One mars from the high risk group aborted at 269 days of gestation, another mare from the high risk group had a dystocia and the mare and foal died. One mare from the normal group presented with precocious signs of imminent parturition at 304 days of gestation. The mare foaled a weak small foal age foal at 310 days. All other mares foaled at full term. The 27 placentas were examined and samples obtained for histopathological evaluation. From the group of 16 normal mares, 11 healthy strong foals were delivered. Only 6 healthy strong foals were delivered from the 14 "high risk" mares.

 

Research in Progress – To encourage informed use of modern genetic technology and techniques
 
Project Title The development of horse embryonic stem cells (eESCs)
RIRDC Project No.: UMO-36A
Start Date: 01-Jul-2005
Finish Date: 01-Jul-2008
Researcher:  Prof Alan Trounson
Organisation: Monash University
Phone: (03) 9905 0771
Fax: (03) 9905 0780
Email: alan.trounson@med.monash.edu.au
Objectives · The project aims to develop pluripotential equine embryonic stem cells (eESCs) from morulae, blastocysts by separation and culture of the ICM from the horse blastocyst. This method has been used to derive mouse and primate ESCs that are immortal and capable of differentiation into all the cells of the organism. In addition, we propose to derive equine specific eESCs (ES-ESCs) by the insertion of horse somatic cell nuclei and mitochondria into enucleated mouse, cattle or rabbit eggs to isolate eESCs from xenogenic embryos. eESCs cell will be characterised by methods used for mice, primate and humans.
Current Progress The research completed to date has involved isolation of inner cell mass from in vivo derived horse embryos and in vitro derived interspecies nuclear transfer embryos. Cell lines from putative trophectoderm and inner cell mass generated either bisecting inner cell mass from the embryos or using anti-horse, anti-trophectoderm antibody. Initial characterisation of cell lines have been carried out using markers of undifferentiated cells. Transmission electron microscopy studies were conducted to understand morphology of horse embryos. Putative trophectoderm cell lines were expanded using routine tissue cell culture methods without feeder cell layers while putative inner cell mass cell lines were maintained on fibroblast feeder cell layer. Established cell lines were frozen for future analyses, cell expansion and generation of polyclonal antibodies against trophectoderm. Two elite cell lines from thoroughbred horse, rabbit, cattle and mouse cell lines have been established for nuclear transfer studies. Interspecies nuclear transfer have been explored using mice and cattle oocytes. Interspecies nuclear transfer with mouse oocytes was not successful while limited success was obtained using cattle oocytes. One putative inner cell mass and trophoectoderm cell line was established from interspecies (horse-cattle) nuclear transfer embryo expressing markers similar to cell lines derived from in vivo embryos.

 

Research in Progress – To encourage informed use of modern genetic technology and techniques
 

Project Title
Development of improved treatment and prevention strategies for inflammatory airway disease of horses
RIRDC Project No.: US-118A
Researcher:  Dr Jennifer Hodgson
Organisation: The University of Sydney
Phone: (02) 4655 0760
Fax: (02) 4655 6942
Email:  jennih@camden.usyd.edu.au
Objectives · The outcome of this project will be the development of specific recommendations regarding management strategies and pharmaceutical treatment for the control of Inflammatory Airway Disease (IAD) in young performance horses. These guidelines will be of value to owners, trainers and veterinarians and will have positive welfare implications.
Current Progress Inflammatory Airway Disease (IAD) is a highly prevalent respiratory condition in young performance horses. Exposure to inhaled insults within the stable environment including endotoxin, acts to directly irritate airway mucosa resulting in increased inflammatory cells and excess mucus production which may plug airways and adversely affect performance. 

To date, studies have determined endotoxin concentrations in specific feeds and bedding materials in order to give detailed advice regarding stable management. In addition a randomised clinical trial is being conducted in Sydney metropolitan racing stables to assess the efficacy of inhaled medications using coupling devices tailored for aerosol drug administration in the horse. Efficacy of treatment is being evaluated via endoscopy (mucus score) and cytological and bacteriological evaluation of tracheal aspirates . 

Since commencing the study in March 2004, results have been presented at a number of forums; 

·10 Veterinary Comparative Respiratory Society, Montreal CANADA

·11 Sydney University Post-Graduate Society

·12 French Association of Equine Practitioners (AEVF)

·13 World Equine Airways Symposium, Cornell USA

·14 Veterinary Comparative Respiratory Society, Jena GERMANY

·15 Sydney metropolitan and provincial Thoroughbred trainers

·16 Racing NSW Forensic Laboratory 

·17 Practicing equine veterinarians

Results will have important practical implications regarding advice to trainers and owners on stable feed and bedding choices and effective pharmaceutical treatment strategies for disease resolution. In addition, we aim to recommend appropriate drug withdrawal times.

Research in Progress – Nutrition Research – Development of better ways to feed horses
 
Project Title Understanding and managing variable starch digestion in the horse
RIRDC Project No.: UNE-87A
Start Date: 30-Jul-03
Finish Date: 30-Jun-06
Researcher:  Dr Geoff Hinch
Organisation: University of New England
Phone: (02) 6773 2202
Fax: (02) 6773 3275
Email: jrowe@metz.une.edu.au
Objectives · To demonstrate that under commercial training conditions, those horses fed diets likely to produce extensive fermentation of starch in the hindgut have more problems with respect to health, adverse behaviour and poor performance than similar animals fed diets likely to produce little or no fermentable starch for hindgut fermentation.

· The research will focus on identifying simple measurements that can be made on individual horses to determine their ability to digest starch efficiently so that diets can be objectively tailored for the requirements and ability of each horse.

· To investigate combinations of exogenous enzymes (amylase and amylogucosidase) to ensure that starch is completely digested in the small intestine prior to the hindgut.

· The major outcome will be to have clear evidence that hindgut starch fermentation is highly undesirable and to have practical, cost effective methods of overcoming the problem.

Current Progress · Mornings were the most reliable time for the actual collection of faecal data. Faecal pH varied most significantly due to the time of day of sampling. Morning pH readings were significantly (<.0001) higher than the noon or evening readings. 

· There was some between trainer variation for faecal pH 

· Dry matter and pH are significantly correlated.

· Further investigation of the usefulness of pH testing as a diagnostic for hind-gut health in the equine and the way in which this relates to other health parameters is the focus of the next part of the experiment. Behavioural characteristics, hoof parameters and blood insulin & glucose are being investigated at a commercial racing establishment to determine the correlation between faecal pH and these health & welfare indicators in the horse.

· pH at different stages of training and on rest and race days will be recorded to determine the variation in hindgut pH that occurs in the horse during the course of race training.

· Faecal pH of performance horses will also be investigated to determine if these horses display the same variations in faecal and behavioural parameters as racing horses.


 

Research in Progress – Lameness and limb injury – Developing more effective methods of prevention, diagnosis and treatment
 
Project Title Laminitis preventive and therapeutic strategies
RIRDC Project No.: UQ-118A
Start Date: 01-Oct-2004
Finish Date: 30-May-2007
Researcher:  Prof Christopher Pollitt
Organisation: The University of Queensland
Phone: (07) 3365 2063
Fax: (07) 3365 1899
Email: c.pollitt@mailbox.uq.edu.au
Objectives · To understand how laminitis develops at the molecular level to formulate strategies for diagnosis, prevention and treatment.

· To analyse the lesions of acute and chronic laminitis and develop strategies for diagnosis, prevention and treatment.

Current Progress Laminitis is an enzyme based disease involving not only MMP-2 but membrane type MMP (MT1-MMP) as well. MT1-MMP activates MMP-2 and cleaves the laminin-5 (L-5) filaments anchoring the lamellar hoof to the distal phalanx. L-5 cleavage creates fragments that are potent triggers of MMP activation and cell migration. We have sequenced the equine L-5 dIII fragment to derive an antibody that shows, in laminitis affected tissue, the presence of dIII at the lamellar interface suggesting that dIII may have triggered the laminitis pathology. Hindgut epithelium is also rich in L-5 and hindgut damage during fructan overload may generate sufficient dIII to circulate to the feet and trigger laminitis. We are producing a recombinant dIII protein to test its efficacy as a laminitis trigger factor and develop ways of inhibiting its impact. Our molecular fluorescent in situ hybridisation (FISH) probes identify the hindgut bacteria involved in fructan induced laminitis. Four hours post fructan consumption Streptococcus bovis/equinus bacteria bloom exponentially (with concomitant lactic acid production) and are the predominant fructan-utilising organisms isolated prior to the onset of lameness. E.coli and Lactobacilli appear 24h post fructan consumption and after laminitis development thus downplaying the role of Gram –ve endotoxins in laminitis development. Circulating cold water at 10C (cryotherapy) applied to all 4 legs for 3 days successfully prevents clinical laminitis and laminitis histopathology. This is the first scientifically proven preventive for acute laminitis. Serial retrograde venography of the feet of horses developing chronic laminitis showed that horses with severe laminitis developed progressively greater venographic changes (especially filling deficits). Magnetic resonance microscopy (MRM), using ‘research only’ ultra-high field scanners, creates images of the hoof wall lamellae and papillae. Thus MRM can non-invasively detect laminitis early enough for effective therapies to improve the outcome for laminitic horses.

 

Research in Progress - Other
 
Project Title Epaxial musculature and its relationship with back pain in the horse
RIRDC Project No.: UQ-111A
Start Date: 01-Jan-04
Finish Date: 31-Dec-05
Researcher:  Dr Catherine McGowan
Organisation: The University of Queensland
Phone: (07) 5460 1521
Fax: (07) 5460 1444
Email: hossas@uqg.uq.edu.au
Objectives · To objectively measure the equine epaxial muscles

· To objectively measure the response of equine epaxial muscles to back pain syndromes

· To correlate clinical signs, ultrasonography, algometry and EMG analysis in affected horses

· To develop ultrasonography as a non-invasive tool for diagnosis of muscular dysfunction associated with back pain and for monitoring response to therapy of back pain in horses

Current Progress The use of ultrasonography to measure equine epaxial muscles has been validated, and anatomy, biomechanics and anatomical variations of the thoracic, lumbar and pelvic back region of horses documented and submitted for publication completing phases 1 and 2 of the project. This project is now in its third and final phase where horses suffering from back pain are being recruited and clinical assessment, ultrasonography and algometry are being correlated. We have been very fortunate to have been invited to collaborate with the Hong Kong Jockey Club and their Head veterinarian, Dr. Chris Riggs in this phase of the study. This has allowed much more detailed histories on clinical cases to be obtained and also post-mortem data to be collected to validate antemortem findings. Narelle Stubbs was successful in obtaining a UQ travel grant to support this intensive phase of work and she has been working in Hong Kong from April and will be there till July 2006. The project is on target for completion and final report by December 2006.

 

Research in Progress - Other
 
Project Title Role of bacteria and lactic acid in the pathogenesis of gastric ulceration
RIRDC Project No.: UQ-115A
Start Date: 01-Aug-04
Finish Date: 05-Jul-07
Researcher:  Dr Rafat Al Jassim
Organisation: The University of Queensland
Phone: (07) 5460 1521
Fax: (07) 5460 1444
Email: raj@sas.eq.edu.au
Objectives · Establish involvement of lactic acid producing bacteria and their products (VFA & Lactic acid) in the pathogenesis of gastric ulceration in horses.

· Determine the effect of contrasting dietary regimens on the microbial contribution to the build-up of lactic acid and VFAs in the non-glandular portion of the stomach.

Current Progress Phase II

A feeding trial was carried out using dietary manipulation to induce stomach ulcers in thoroughbred horses. The experimental schedule consisted of 4 months of pasture feeding to condition the horses and guarantee ulcer free stomachs at the start of the experiment, 2 weeks acclimation, followed by an 8 week treatment period. During the treatment period horses were kept in individual stables at the Equine Unit, Gatton, fed the experimental diets and trained 5 days a week on a horse walker. The daily experimental diets were: 1. lucerne hay (6kg) and oats (3kg) for the 1st 2 weeks adaptation period; 2. Lucerne hay (5 kg) + concentrate (4 kg) for the next 4 weeks; and 3. lucerne hay (3 kg) + concentrate (5 kg) for the final 4 weeks concentrate feeding period. Horses were fed twice daily and endoscoped fortnightly. Samples from stomach contents and biopsies from the healthy and ulcerated stomach lining were collected. Genomic DNA was extracted from all samples, PCR amplified and prepared for denaturing gradient gel electrophoresis (DGGE) analysis. The experimental protocol was successful in inducing ulcers of variable grades in 11 horses out of the 12 horses used in the trial. It is interesting to note here that 4 horses out of the 12 had ulcers in their stomachs at the start of the treatment period after 4 months on pastures. Work is in progress to reveal the composition of the bacterial community in ulcerated stomachs and that adhered to ulcerated and healthy stomach lining. Work should be completed by October and final report will be available by end of Nov 2006.

Navigation Icons
Site map
Contact us
Feedback
Links
Disclaimer
Privacy Statement

Last updated: August 2006    Copyright © RIRDC  2006
http://www.rirdc.gov.au/comp06/hor2.html